Rethinking EDC: Why AI Demands a New Foundation for Clinical Data Management
At Veeva R&D and Quality Summit 2025, we spoke with Manny Vazquez, Senior Director of Clinical Data Strategy at...
Moe Alsumidaie
New GCP Revision Redefines Vendor Oversight and Digital Accountability
At SCOPE Europe 2025, experts underscored that the revised International Council for Harmonisation (ICH) Good Clinical Practice (GCP) guideline,...
How Big Pharma is Rethinking Regulatory Operations in the Digital Era
At the 2025 Indegene Digital Summit, a high-level panel of regulatory executives from Pfizer, Novartis, and Boehringer Ingelheim gathered...
Europe’s Clinical Trial Exodus: Can the Region Regain Its Competitive Edge?
At the SCOPE 2025 Europe conference, during a panel titled, “Trials Are Leaving Europe — Can We Bring Them...
Redefining Clinical Imaging: How a Site-First Approach is Setting a New Standard for Transparency and Data Integrity
At DPHARM, we spoke with Patrick McNamara, Chief Commercial Officer at Yunu, about how the company is transforming imaging...
Building Trust Through Transparency: Apellis Pharma’s Steph Viscomi on Lean TMF and Site Collaboration
At the Veeva R&D and Quality Summit, we spoke with Steph Viscomi, Head of TMF at Apellis Pharma, about...
AI at the Crossroads: FDA and Industry Chart a Risk-Based Path for Drug Development
At a landmark FDA workshop on artificial intelligence (AI) in drug development, regulators and industry leaders outlined a vision...
ProofPilot and Lokavant Aquisition: Aligning Trial Ops with Predictive Analytics
In this interview, we sit down with Chris Venezia, CEO, and Joseph Kim, Chief Strategy Officer at ProofPilot, to...
Embedding Patient Advocacy in R&D: The Next Frontier in Pharma Collaboration
At a recent industry panel at SCOPE Europe, experts from advocacy organizations and pharmaceutical companies explored a striking imbalance:...
Pfizer’s AI-Powered Feasibility and Cost Efficiency: The Future of Clinical Trial Recruitment
At the 2025 SCOPE Europe conference, industry leaders examined how artificial intelligence (AI) is reshaping feasibility assessment and patient...